Skip to main content
SSO 2024 Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded for On-Demand Viewing
Recorded for On-Demand Viewing
Back

Jen Jen Yeh, MD

Professor
University of North Carolina at Chapel Hill

Jen Jen Yeh, MD
Professor of Surgery and Pharmacology
University of North Carolina at Chapel Hill
Chapel Hill, NC

Dr. Yeh is a Professor in the Division of Surgical Oncology and Departments of Surgery and Pharmacology at the University of North Carolina (UNC) at Chapel Hill. She has leadership roles in the Department of Surgery as the Vice Chair for Research and is co-Director of the Clinical Research Program and co-Associate Director for Education for the Lineberger Comprehensive Cancer Center.

Dr. Yeh received her B.A. from Wesleyan University. Prior to receiving her medical degree from the Johns Hopkins University School of Medicine, she worked in the laboratory of Dr. William G. Kaelin, Jr. After completing a general surgery residency at Boston Medical Center, during which she was a post-doctoral fellow in the laboratories of Dr. Charis Eng and Dr. William R. Sellers, she went on to become a surgical oncology fellow at the Memorial-Sloan Kettering Cancer Center. After joining the faculty at UNC Chapel Hill in 2005, she worked with Dr. Channing Der until 2008 while establishing herself as an independent investigator.

Currently, in addition to an active surgical oncology practice that focuses on the care of patients with endocrine and pancreatic cancers, Dr. Yeh has devoted her research interests to focus on identifying key proteins that explain why and how pancreatic cancers metastasize, and inform treatment. She has taken on a multidisciplinary approach (biomedical engineering, chemistry, genomics, proteomics, biostatistics) to tackle the complexities of pancreatic cancer and has established an infrastructure for the preclinical evaluation of therapeutic agents with the long-term goal of identifying promising therapies for pancreatic cancer and accelerating their translation to the clinic.

Presentation(s):